01911.HK
China Renaissance Holdings Limited
HKSE · Financial Services · Financial - Capital Markets · CN
HKD 3.58
−1.65%Sep 15, 2026, 07:00 UTC
AlphaPai, an AI investment research assistant developed by Rabyte Technology, completed a US$50 million Series B funding round with participation from China Insurance Investment, GF Xinde Investment Management, Qiming Venture Partners, Ambrum Capital, Next Capital, Trustar Capital and Eastern Bell Capital, with China Renaissance as exclusive financial advisor.
Source:Sep 15, 2026, 03:55 UTC
Chinese embodied-AI humanoid robotics company Chaowei Dongli completed an angel+ series funding round of over RMB 500 million, led by Vertex Ventures (Temasek-backed), with participation from Fangguang Capital and Wanshi Capital, and China Renaissance as exclusive financial advisor.
Source:Sep 14, 2026, 08:58 UTC
Xuntu Technology completed a Series B funding round of over RMB 300 million, with investors including China Insurance Investment, GF Xinde Investment Management, Qiming Venture Partners, Amber Capital, Jiacheng Capital, CITIC Capital, and Eastern Bell Capital, while China Renaissance continued to serve as exclusive financial advisor.
Source:Sep 3, 2026, 02:37 UTC
NeuShen Therapeutics announced the completion of an oversubscribed Series B financing round of over $80 million on September 3, 2026.
Source:Aug 27, 2026, 09:15 UTC
China Renaissance Holdings reported interim results for the six months ended June 2026, with net profit of RMB 40.47 million, down 37.7% year-on-year, and revenue of RMB 412 million, down 3.0%.
Source:Aug 17, 2026, 02:00 UTC
Mifeng Technology completed a new round of financing worth hundreds of millions of yuan, led by China Telecom, with Zhangjiang Group following and existing shareholders China Renaissance and Yuanqi Innovation increasing their investments.
Jul 20, 2026, 01:46 UTC
China Renaissance Holdings announced that Liu Taojiang joined the company as Managing Director and Head of Hong Kong Stock Investment Banking.
Source: